Oxybutynin Tablet, Film Coated, Extended Release
NDC Package 68382-256-01

The code 68382-256-01 identifies a specific commercial package of 100 tablet, film coated, extended release in 1 bottle of Oxybutynin, a human prescription drug labeled by Zydus Pharmaceuticals Usa Inc.. This tablet, film coated, extended release is formulated for oral use and contains oxybutynin chloride as the active substance.

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Zydus Pharmaceuticals Usa Inc. on August 10, 2017. The current certification is valid through December 31, 2026.

Oxybutynin is used to treat an overactive bladder. By relaxing the muscles in the bladder, oxybutynin improves symptoms such as the inability to control urination (incontinence), feeling that one has to urinate (urgency), and having to go to the bathroom often (frequency). This medication belongs to the class of drugs known as antispasmodics. This medication is not recommended for use in children younger than 5 years of age. Consult your doctor for more information. Unless otherwise directed by your doctor, the over-the-counter product should only be used by adult women who have symptoms of overactive bladder for at least 2 months. For over-the-counter products, carefully read the package instructions to make sure the product is right for you. Check the ingredients on the label even if you have used the product before. The manufacturer may have changed the ingredients. Also, products with similar names may contain different ingredients meant for different purposes. Taking the wrong product could harm you.

For medical billing and reimbursement, this package follows the 11-digit CMS format: 68382025601. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.